187 related articles for article (PubMed ID: 23059885)
1. Prox 1, VEGF-C and VEGFR3 expression during cervical neoplasia progression as evidence of an early lymphangiogenic switch.
Cimpean AM; Mazuru V; Saptefrati L; Ceausu R; Raica M
Histol Histopathol; 2012 Dec; 27(12):1543-50. PubMed ID: 23059885
[TBL] [Abstract][Full Text] [Related]
2. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
4. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells.
Pan MR; Chang TM; Chang HC; Su JL; Wang HW; Hung WC
J Cell Sci; 2009 Sep; 122(Pt 18):3358-64. PubMed ID: 19706680
[TBL] [Abstract][Full Text] [Related]
5. Coordinated lymphangiogenesis is critical in lymph node development and maturation.
Lee YG; Koh GY
Dev Dyn; 2016 Dec; 245(12):1189-1197. PubMed ID: 27623309
[TBL] [Abstract][Full Text] [Related]
6. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
[TBL] [Abstract][Full Text] [Related]
7. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
[TBL] [Abstract][Full Text] [Related]
8. Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades.
Mishima K; Watabe T; Saito A; Yoshimatsu Y; Imaizumi N; Masui S; Hirashima M; Morisada T; Oike Y; Araie M; Niwa H; Kubo H; Suda T; Miyazono K
Mol Biol Cell; 2007 Apr; 18(4):1421-9. PubMed ID: 17287396
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis.
Van Trappen PO; Steele D; Lowe DG; Baithun S; Beasley N; Thiele W; Weich H; Krishnan J; Shepherd JH; Pepper MS; Jackson DG; Sleeman JP; Jacobs IJ
J Pathol; 2003 Dec; 201(4):544-54. PubMed ID: 14648657
[TBL] [Abstract][Full Text] [Related]
10. The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma.
Yu H; Zhang S; Zhang R; Zhang L
J Exp Clin Cancer Res; 2009 Jul; 28(1):98. PubMed ID: 19589137
[TBL] [Abstract][Full Text] [Related]
11. The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors.
Srinivasan RS; Escobedo N; Yang Y; Interiano A; Dillard ME; Finkelstein D; Mukatira S; Gil HJ; Nurmi H; Alitalo K; Oliver G
Genes Dev; 2014 Oct; 28(19):2175-87. PubMed ID: 25274728
[TBL] [Abstract][Full Text] [Related]
12. Detection of early lymphangiogenesis by lymphatic microvascular density and endothelial proliferation status in preneoplastic and neoplastic lesions of the uterine cervix.
Cimpean AM; Mazuru V; Cernii A; Ceausu R; Saptefrati L; Cebanu A; Fit AM; Raica M
Pathol Int; 2011 Jul; 61(7):395-400. PubMed ID: 21707842
[TBL] [Abstract][Full Text] [Related]
13. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
[TBL] [Abstract][Full Text] [Related]
14. Induction of lymphangiogenesis through vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma.
Wakisaka N; Hirota K; Kondo S; Sawada-Kitamura S; Endo K; Murono S; Yoshizaki T
Oral Oncol; 2012 Aug; 48(8):703-8. PubMed ID: 22366442
[TBL] [Abstract][Full Text] [Related]
15. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factors C and D and lymphangiogenesis at the early stage of esophageal squamous cell carcinoma progression.
Kumagai Y; Tachikawa T; Higashi M; Sobajima J; Takahashi A; Amano K; Fukuchi M; Ishibashi K; Mochiki E; Yakabi K; Tamaru J; Ishida H
Dis Esophagus; 2018 Aug; 31(8):. PubMed ID: 29800478
[TBL] [Abstract][Full Text] [Related]
17. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.
Flister MJ; Wilber A; Hall KL; Iwata C; Miyazono K; Nisato RE; Pepper MS; Zawieja DC; Ran S
Blood; 2010 Jan; 115(2):418-29. PubMed ID: 19901262
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and immunofluorescence expression profile of lymphatic endothelial cell markers in oral cancer.
Chutipongpisit K; Parachuru VP; Friedlander LT; Hussaini HM; Rich AM
Int J Exp Pathol; 2021 Dec; 102(6):268-278. PubMed ID: 34791715
[TBL] [Abstract][Full Text] [Related]
19. YAP and TAZ maintain PROX1 expression in the developing lymphatic and lymphovenous valves in response to VEGF-C signaling.
Cha B; Ho YC; Geng X; Mahamud MR; Chen L; Kim Y; Choi D; Kim TH; Randolph GJ; Cao X; Chen H; Srinivasan RS
Development; 2020 Dec; 147(23):. PubMed ID: 33060128
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of miR-1236 in the assessment of tumor lymphangiogenesis in human ovarian cancer patients.
Khademi M; Babaei Z; Ghorbanhosseini SS; Emami Razavi A; Aghaei M
J Gene Med; 2023 May; 25(5):e3480. PubMed ID: 36750632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
